[CANSLIM] HITK

From: "Gene Ricci" <genr@swbell.net>
Subject: [CANSLIM] HITK
Date: Sat, 26 Jul 2003 20:30:06 -0500
Next Article (by Author): Re: [CANSLIM] Another mystery plunge Hong Hsu
Previous Article (by Author): Re: [CANSLIM]EELN "Gene Ricci"
Next in Thread: Re: [CANSLIM] HITK "DMC197807"
Articles sorted by: [Date] [Author] [Subject]
This is a multi-part message in MIME format.

- ------=_NextPart_000_06F8_01C353B4.B31F56A0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

MessageIf you still own HITK there may be a light in the tunnel. Change =
Wave (Tobin Smith) sent an alert to his 300,000 (?) subscribers to buy =
HITK on 7/25. Looking at the chart shows that the price dropped down and =
stabilized at its 200-day moving average at $23.14 before bouncing =
higher. It closed at $24.88 on 7/25. Other than a possible shortfall  =
because of seasonal cough medicine sales I couldn't find any other bad =
news. Anyone know of any other issues?

Thanks,
Gene

I was forwarded the following;

A price under $25 is a great entry point for this dual
generic/diabetes play -- forget the noise from the momentum
buyers-turned-sellers. They were cleaned out with the huge volume
sales, so now it's time to build or add to your positions to get to
a $25 cost basis. I still think we can hold on for a $50 value at
the end of 2004 on $2 per share earnings in 2004.

Let's lower the buy under for HITK to $25.


- ------=_NextPart_000_06F8_01C353B4.B31F56A0
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Message</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Diso-8859-1">
<META content=3D"MSHTML 6.00.2800.1106" name=3DGENERATOR>
<STYLE></STYLE>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV><SPAN class=3D670474503-26072003><FONT face=3D"Comic Sans MS"><FONT =
size=3D4>If=20
you still own HITK there may be a light in the tunnel. Change Wave =
(Tobin Smith)=20
sent an&nbsp;alert to&nbsp;his 300,000 (?) subscribers to buy HITK on =
7/25.=20
<SPAN class=3D670474503-26072003>Looking at&nbsp;the chart shows that =
the=20
price&nbsp;dropped down and stabilized at its 200-day moving average at =
$23.14=20
before bouncing higher. It closed at $24.88&nbsp;on 7/25. Other than a =
possible=20
shortfall&nbsp; because of seasonal cough medicine sales I couldn't find =
any=20
other bad news. Anyone know of any other=20
issues?</SPAN></FONT></FONT></SPAN></DIV>
<DIV><SPAN class=3D670474503-26072003><SPAN =
class=3D670474503-26072003><FONT=20
face=3D"Comic Sans MS" size=3D4></FONT></SPAN></SPAN>&nbsp;</DIV>
<DIV><SPAN class=3D670474503-26072003><SPAN =
class=3D670474503-26072003><FONT=20
face=3D"Comic Sans MS" size=3D4>Thanks,</FONT></SPAN></SPAN></DIV>
<DIV><SPAN class=3D670474503-26072003><SPAN =
class=3D670474503-26072003><FONT=20
face=3D"Comic Sans MS" size=3D4>Gene</FONT></SPAN></DIV>
<DIV><SPAN class=3D670474503-26072003><FONT face=3D"Comic Sans MS"=20
size=3D4></FONT></SPAN>&nbsp;</DIV>
<DIV><FONT face=3D"Comic Sans MS" size=3D4>I was forwarded the=20
following;</FONT></SPAN></DIV>
<DIV><SPAN class=3D670474503-26072003><FONT face=3DArial=20
size=3D2></FONT></SPAN>&nbsp;</DIV>
<DIV><SPAN class=3D670474503-26072003><EM>A price under $25 is a great =
entry point=20
for this dual<BR>generic/diabetes play -- forget the noise from the=20
momentum<BR>buyers-turned-sellers. They were cleaned out with the huge=20
volume<BR>sales, so now it's time to build or add to your positions to =
get=20
to<BR>a $25 cost basis. I still think we can hold on for a $50 value =
at<BR>the=20
end of 2004 on $2 per share earnings in 2004.<BR></EM><BR><EM>Let's =
lower the=20
buy under for HITK to $25.</EM></SPAN></DIV>
<DIV><SPAN class=3D670474503-26072003><FONT face=3DArial=20
size=3D2></FONT></SPAN>&nbsp;</DIV>
<DIV><SPAN class=3D670474503-26072003><FONT face=3DArial=20
size=3D2></FONT></SPAN>&nbsp;</DIV></BODY></HTML>

- ------=_NextPart_000_06F8_01C353B4.B31F56A0--


- -
- -To subscribe/unsubscribe, email "majordomo@xmission.com"
- -In the email body, write "subscribe canslim" or
- -"unsubscribe canslim".  Do not use quotes in your email.
Go to Jeff Salisbury LWGate Home Page.